Trial Profile
Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 03 Jan 2014
Price :
$35
*
At a glance
- Drugs Bosentan (Primary)
- Indications Pulmonary hypertension; Sarcoidosis
- Focus Therapeutic Use
- Acronyms BOSAPAH
- 03 Jan 2014 New trial record